Release date for the financial statements 2012 for NeuroSearch A/S and subsequent telephone conference
Release date for the financial statements 2012 for NeuroSearch A/S and
subsequent telephone conference
The NeuroSearch A/S (NEUR) financial statements 2012 will be released on Friday
8 February 2013.
On the same day, NeuroSearch will host a telephone conference at 9.30 am
Copenhagen time (8.30 am London time, 3.30 am New York time) during which CEO
René Schneider will present the financial statements 2012.
The telephone conference will be conducted in English and the dial-in numbers
· UK: +44 (0) 844 571 8957
· US: +1 866 682 8490
· Denmark: +45 32 72 80 18
Listening to the telephone conference is also possible via the company's
website, www.neurosearch.com, where also the corresponding presentation will be
available at the time of the telephone conference.
René Schneider, CEO, telephone: +45 4460 8700 or +45 2911 2097
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S. The company’s
product pipeline comprises ordopidine and seridopidine, which have both
completed phase I studies, as well as tesofensine, which has completed phase
II, and NS2359 which has completed phase I.
All drug candidates exert their effect in the central nervous system.